Intervention For AYAS With Cancer Risk Syndromes

Purpose

This research is being done because there is a need to improve cancer risk communication and decision-making among adolescents and young adults. In this study, the investigators are looking at whether using a chatbot and online portal for cancer risk information helps improve communication and decision-making. - Over 70,000 adolescents and young adults (AYAs) are diagnosed with cancer in the U.S. every year and up to 10% have genetic changes (or, mutations) that put them at a higher risk of developing new cancers during their lifetimes. These genetic mutations can result in cancer risk syndromes (such as, Lynch Syndrome or Li-Fraumeni Syndrome). Identifying cancer risk syndromes can allow for screening and early diagnosis of future cancers, which could ultimately save lives and offer more care choices for patients. As a result, genetic counseling and testing for cancer risk syndromes is being recommended more for Adolescents and Young Adults with new cancer diagnoses, regardless of family history. - This research study to develop an intervention called AYA-RISE that aims to assist AYAs with cancer risk communication and decision-making around their caregivers.

Condition

  • Cancer Risk Syndrome

Eligibility

Eligible Ages
Between 12 Years and 24 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Criteria

Inclusion Criteria:

- Across all study aims, we will enroll AYA patients, family members/caregivers, and
providers.

AIM 1, PART 1 - STAKEHOLDER INTERVIEWS

AYA Patients

1. Ages 12-24 years, inclusive

2. Diagnosed with a cancer risk syndrome

3. English-speaking and -reading

4. Receiving care at any of the study sites OR participating in the LiFraumeni Syndrome
Association (LFSA) Youth Conference

5. Adequate cognitive function per NeuroQOL indicated by a score of 30 or greater

6. Not receiving active cancer therapy

Family caregivers-Inclusion Criteria

1. Parent/guardian, spouse/partner, or other family member who participates in the care
of AYAs aged 12-24 with cancer risk syndromes

2. English-speaking and -reading

3. At any of the study sites

Providers Inclusion Criteria (Oncologists, nurses, genetic counselors, social workers, or
psychologists)

1. English-speaking and reading

2. Caring for AYAs aged 12-24 with cancer risk syndromes at any of the study sites

AIM 1, PART 2 - INTERVENTION PILOT

AYA Patients

1. Ages 12-24 years, inclusive

2. Diagnosed with a cancer risk syndrome

3. English-speaking and -reading

4. Receiving care at Dana-Farber Cancer Institute

5. Adequate cognitive function per NeuroQOL, indicated by a score of 30 or greater

6. Not receiving active cancer therapy

7. Did not participate in a stakeholder interview

Eligibility notes:

- Family caregivers of participating 12-17y patients will be eligible to participate
in the pilot

- 12-17y patients can participate without a family member if both the patient and
family member agree.

- Patients 18-24y will have the option to participate with or without a family member.

AIM 2 - RANDOMIZED TRIAL

AYA Patients

1. Ages 12-24 years, inclusive

2. Diagnosed with a cancer risk syndrome

3. English-speaking and reading

4. Has a planned post-disclosure genetic counseling or follow-up visit at any of the
study sites

5. Adequate cognitive function per NeuroQOL, indicated by a score of 30 or greater

6. Not receiving active cancer therapy

7. Did not participate in either part of Aim 1 (interview or pilot)

Family caregivers

1. Parent/guardian, spouse/partner, or other family member who participates in the care
of AYAs aged 12-24 with cancer risk syndromes

2. English-speaking and -reading

3. At any of the study sites

4. Did not participate in either part of Aim 1 (interview or pilot)

AIM 3 - SEMI-STRUCTURED INTERVIEWS AYA Patients, Family Caregivers, Providers, and Site
PIs

1. Participated in the intervention arm of Aim 2, or

2. Is a site principal investigator at one of the 4 participating study sites

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Health Services Research
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
No Intervention
Aim 1-Part 1 Stakeholder Interview
This arm will focus on finding the best format for the study intervention (called AYA-RISE) whether AYA-RISE is easy to use; and whether patients, family caregivers, and providers find AYA-RISE acceptable. The research study procedures include: - Using and reviewing AYA-RISE - Participating in audio-recorded, 30-minute interviews
Experimental
Aim 1-Part 2
This arm is a pilot study of the study intervention (called AYA-RISE). The activities involved in this part of the study are: - Baseline Questionnaire - Using and reviewing AYA-RISE - Follow-up Questionnaire - Brief interviews to get feedback on AYA-RISE
  • Behavioral: AYA-RISE Adolescents and Young Adults Risk Information and Screening Education
    A chatbot is a computer program that can chat with humans. The text the chatbot uses to talk with humans was created by real people, but the chatbot itself is not a real person. A company called Clear Genetics developed the original chatbot and patient portal, and this study team customized it for this research study.
    Other names:
    • AYA-RISE
Active Comparator
Aim 2-Genetic Counseling
The names of the study activities involved in this study are: - Baseline Questionnaire - Follow-up Questionnaire - Medical record review The study procedures will all take place on the day of the patient's regularly scheduled clinic visit. Participants will be in this research study for up to 1 year.
  • Behavioral: Standard clinical visit for genetic counseling
    Standard clinical visit for genetic counseling and follow up
Experimental
Aim 2- Genetic Counseling with AYA-RISE
The names of the study activities involved in this study are: - Baseline Questionnaire - Follow-up Questionnaire - Medical record review - Using the study intervention, AYA-RISE The study procedures will all take place on the day of the patient's regularly scheduled clinic visit. Participants will be in this research study for up to 1 year.
  • Behavioral: AYA-RISE Adolescents and Young Adults Risk Information and Screening Education
    A chatbot is a computer program that can chat with humans. The text the chatbot uses to talk with humans was created by real people, but the chatbot itself is not a real person. A company called Clear Genetics developed the original chatbot and patient portal, and this study team customized it for this research study.
    Other names:
    • AYA-RISE
No Intervention
Aim 3 Semi-structured interviews
Each site will conduct 30-minute interviews with patients, caregivers, and providers, and site principal investigators.

Recruiting Locations

Boston Children's Hospital
Boston, Massachusetts 02115
Contact:
Jennifer Mack, MD
617-632-6622
JMACK@PARTNERS.ORG

Dana Farber Cancer Institute
Boston, Massachusetts 02115
Contact:
Jennifer Mack, MD
617-632-6622
JMACK@PARTNERS.ORG

More Details

Status
Recruiting
Sponsor
Dana-Farber Cancer Institute

Study Contact

Jennifer Mack, MD
(617) 632-6622
JMACK@PARTNERS.ORG

Detailed Description

This research study involves three aims (Aims 1, 2, and 3). - Aim 1, Part 1, which focuses on finding the best format for the study intervention (called AYA-RISE); whether AYA-RISE is easy to use; and whether patients, family caregivers, and providers find AYA-RISE acceptable.The research study procedures include: - Using and reviewing AYA-RISE, - Participating in audio-recorded, 30-minute interviews - Aim 1, Part 2, which is a pilot study of the study intervention (called AYA-RISE). In this pilot study, the investigators are looking at whether AYA-RISE is easy to use and what participants think of it. -- The activities involved in this part of the study are: - Baseline Questionnaire - Using and reviewing AYA-RISE - Follow-up Questionnaire - Brief feedback interviews on AYA-RISE - In Aim 2, participants will be randomized trial into one of two groups; - Group 1: Standard Genetic Counseling/follow-up visit or - Group 2 : Standard Genetic Counseling/follow-up visit and Access to AYA-Rise - Aim 3: Semi-Structured Interviews: - Evaluate implementation outcomes using 28 semi-structured interviews with patients, family members, providers, and site principal investigators